US$ 21.05
digital health companies glp-1 weight loss research2guidance Novo Nordisk seeks digital health
Description
GLP-1s aid in controlling appetite through a series of complex brain signaling pathways, making you feel full faster

GLP-1 drugs have been linked to several eye problems, including: Non-arteritic anterior ischemic optic neuropathy (NAION) Optic neuropathy Retinal ischemia Exacerbation of diabetic retinopathy These GLP-1 eye problems can range from mild visual field defects to complete blindness in one eye

The goal is to help everyone understand the rhythm of gameplay, make informed decisions, and maintain control over both time and budget

doi: 10.1159/000485776 32 ShahZKampfrathTDeiuliisJAZhongJPinedaCYingZet al

About 1 in 8 adults surveyed reported having ever taken a GLP-1 drug with 1 in 16 currently taking one

Im not taking away from the manufacturers who developed it because Im not eligible to get their product
